These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8840936)

  • 21. Nucleic acid-based modulation of cardiac gene expression for the treatment of cardiac diseases. Approaches and perspectives.
    Poller W; Fechner H; Kurreck J; Pauschinger M; Kühl U; Erdmann VA; Lamers JM; Schultheiss HP
    Z Kardiol; 2004 Mar; 93(3):171-93. PubMed ID: 15024585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension.
    Phillips MI
    Hypertension; 1997 Jan; 29(1 Pt 2):177-87. PubMed ID: 9039099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene transfer and kidney disease.
    Imai E; Isaka Y; Akagi Y; Kaneda Y; Hori M
    J Nephrol; 1998; 11(1):16-9. PubMed ID: 9561480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic manipulation of the kidney.
    Kitamura M; Fine LG
    Pediatr Nephrol; 1997 Dec; 11(6):773-7. PubMed ID: 9438664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic nucleic acids: current clinical status.
    Sridharan K; Gogtay NJ
    Br J Clin Pharmacol; 2016 Sep; 82(3):659-72. PubMed ID: 27111518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene delivery in renal tubular epithelial cells using recombinant adeno-associated viral vectors.
    Chen S; Agarwal A; Glushakova OY; Jorgensen MS; Salgar SK; Poirier A; Flotte TR; Croker BP; Madsen KM; Atkinson MA; Hauswirth WW; Berns KI; Tisher CC
    J Am Soc Nephrol; 2003 Apr; 14(4):947-58. PubMed ID: 12660329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene and other biological therapies for vascular diseases.
    Stephan D; Nabel EG
    Fundam Clin Pharmacol; 1997; 11(2):97-110. PubMed ID: 9107554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene therapy targeting kidney diseases: routes and vehicles.
    Isaka Y
    Clin Exp Nephrol; 2006 Dec; 10(4):229-35. PubMed ID: 17186326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nucleic-acid therapeutics: basic principles and recent applications.
    Opalinska JB; Gewirtz AM
    Nat Rev Drug Discov; 2002 Jul; 1(7):503-14. PubMed ID: 12120257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease.
    Kaucsár T; Rácz Z; Hamar P
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1390-401. PubMed ID: 20940025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cellular high-throughput screening approach for therapeutic trans-cleaving ribozymes and RNAi against arbitrary mRNA disease targets.
    Yau EH; Butler MC; Sullivan JM
    Exp Eye Res; 2016 Oct; 151():236-55. PubMed ID: 27233447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oligonucleotide therapeutics: clothing the emperor.
    Gewirtz AM
    Curr Opin Mol Ther; 1999 Jun; 1(3):297-306. PubMed ID: 11713794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of renal glomerular disease using remote delivery of adenoviral-encoded solubletype II TGF-beta receptor fusion molecule.
    Haviv YS; Takayama K; Nagi PA; Tousson A; Cook W; Wang M; Lam JT; Naito S; Lei X; Carey DE; Curiel DT
    J Gene Med; 2003 Oct; 5(10):839-851. PubMed ID: 14533192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical genetics at the crossroads: the example of hereditary kidney diseases].
    Grünfeld JP
    Bull Mem Acad R Med Belg; 2001; 156(10-12):491-6; discussion 496-7. PubMed ID: 12371269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene therapy for renal diseases.
    Lien YH; Lai LW
    Kidney Int Suppl; 1997 Oct; 61():S85-8. PubMed ID: 9328975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How will gene therapy apply to the kidney in the 21st century?
    Kone BC
    Semin Nephrol; 2000 Jan; 20(1):47-59. PubMed ID: 10651218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular and molecular neurosurgery: pathways from concept to reality--part I: target disorders and concept approaches to gene therapy of the central nervous system.
    Zlokovic BV; Apuzzo ML
    Neurosurgery; 1997 Apr; 40(4):789-803; discussion 803-4. PubMed ID: 9092853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene therapy for renal disorders.
    Lien YH; Lai LW
    Expert Opin Biol Ther; 2004 Jun; 4(6):919-26. PubMed ID: 15174973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Approaches and methods in gene therapy for kidney disease.
    van der Wouden EA; Sandovici M; Henning RH; de Zeeuw D; Deelman LE
    J Pharmacol Toxicol Methods; 2004; 50(1):13-24. PubMed ID: 15233963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy with antisense TGF-beta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice.
    Han DC; Hoffman BB; Hong SW; Guo J; Ziyadeh FN
    Am J Physiol Renal Physiol; 2000 Apr; 278(4):F628-34. PubMed ID: 10751224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.